Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2a Study of IW-9179 to Treat Functional Dyspepsia

NCT01712412 is registered in ClinicalTrials.gov with Ironwood Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01712412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01712412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2a Study of IW-9179 to Treat Functional Dyspepsia
Lead sponsor
Ironwood Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2012
Completion date
March 31, 2014
Enrollment
10 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

dyspepsia, functional gastrointestinal disorders